cloudfront

Report Detail



OtherGlobal Hepatitis B and C Diagnostics Market Size, Status and Forecast 2025

  • RnM2315768
  • |
  • 8 August, 2018
  • |
  • Global
  • |
  • 102 pages
  • |
  • QYResearch
  • |
  • Other

Global Hepatitis B and C Diagnostics Market Size, Status and Forecast 2025

Table of Contents

    Global Hepatitis B and C Diagnostics Market Size, Status and Forecast 2025

      1 Industry Overview of Hepatitis B and C Diagnostics

      • 1.1 Hepatitis B and C Diagnostics Market Overview
        • 1.1.1 Hepatitis B and C Diagnostics Product Scope
        • 1.1.2 Market Status and Outlook
      • 1.2 Global Hepatitis B and C Diagnostics Market Size and Analysis by Regions (2013-2018)
        • 1.2.1 United States
        • 1.2.2 Europe
        • 1.2.3 China
        • 1.2.4 Japan
        • 1.2.5 Southeast Asia
        • 1.2.6 India
      • 1.3 Hepatitis B and C Diagnostics Market by Type
        • 1.3.1 Hepatitis B
        • 1.3.2 Hepatitis C
      • 1.4 Hepatitis B and C Diagnostics Market by End Users/Application
        • 1.4.1 Immunodiagnostics
        • 1.4.2 Nucleic Acid Test (NAT)

      2 Global Hepatitis B and C Diagnostics Competition Analysis by Players

      • 2.1 Hepatitis B and C Diagnostics Market Size (Value) by Players (2013-2018)
      • 2.2 Competitive Status and Trend
        • 2.2.1 Market Concentration Rate
        • 2.2.2 Product/Service Differences
        • 2.2.3 New Entrants
        • 2.2.4 The Technology Trends in Future

      3 Company (Top Players) Profiles

      • 3.1 Roche Diagnostics
        • 3.1.1 Company Profile
        • 3.1.2 Main Business/Business Overview
        • 3.1.3 Products, Services and Solutions
        • 3.1.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
      • 3.2 Abbott
        • 3.2.1 Company Profile
        • 3.2.2 Main Business/Business Overview
        • 3.2.3 Products, Services and Solutions
        • 3.2.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
      • 3.3 Siemens
        • 3.3.1 Company Profile
        • 3.3.2 Main Business/Business Overview
        • 3.3.3 Products, Services and Solutions
        • 3.3.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
      • 3.4 Qiagen
        • 3.4.1 Company Profile
        • 3.4.2 Main Business/Business Overview
        • 3.4.3 Products, Services and Solutions
        • 3.4.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
      • 3.5 Alere
        • 3.5.1 Company Profile
        • 3.5.2 Main Business/Business Overview
        • 3.5.3 Products, Services and Solutions
        • 3.5.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
      • 3.6 bioMérieux
        • 3.6.1 Company Profile
        • 3.6.2 Main Business/Business Overview
        • 3.6.3 Products, Services and Solutions
        • 3.6.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
      • 3.7 Cepheid
        • 3.7.1 Company Profile
        • 3.7.2 Main Business/Business Overview
        • 3.7.3 Products, Services and Solutions
        • 3.7.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
      • 3.8 Chembio Diagnostics
        • 3.8.1 Company Profile
        • 3.8.2 Main Business/Business Overview
        • 3.8.3 Products, Services and Solutions
        • 3.8.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
      • 3.9 DiaSorin
        • 3.9.1 Company Profile
        • 3.9.2 Main Business/Business Overview
        • 3.9.3 Products, Services and Solutions
        • 3.9.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
      • 3.10 Enzo Life Sciences
        • 3.10.1 Company Profile
        • 3.10.2 Main Business/Business Overview
        • 3.10.3 Products, Services and Solutions
        • 3.10.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
      • 3.11 Hologic
      • 3.12 MedMira
      • 3.13 OraSure Technologies
      • 3.14 Quest Diagnostics
      • 3.15 Quidel Corp
      • 3.16 Randox Laboratories

      4 Global Hepatitis B and C Diagnostics Market Size by Type and Application (2013-2018)

      • 4.1 Global Hepatitis B and C Diagnostics Market Size by Type (2013-2018)
      • 4.2 Global Hepatitis B and C Diagnostics Market Size by Application (2013-2018)
      • 4.3 Potential Application of Hepatitis B and C Diagnostics in Future
      • 4.4 Top Consumer/End Users of Hepatitis B and C Diagnostics

      5 United States Hepatitis B and C Diagnostics Development Status and Outlook

      • 5.1 United States Hepatitis B and C Diagnostics Market Size (2013-2018)
      • 5.2 United States Hepatitis B and C Diagnostics Market Size and Market Share by Players (2013-2018)
      • 5.3 United States Hepatitis B and C Diagnostics Market Size by Application (2013-2018)

      6 Europe Hepatitis B and C Diagnostics Development Status and Outlook

      • 6.1 Europe Hepatitis B and C Diagnostics Market Size (2013-2018)
      • 6.2 Europe Hepatitis B and C Diagnostics Market Size and Market Share by Players (2013-2018)
      • 6.3 Europe Hepatitis B and C Diagnostics Market Size by Application (2013-2018)

      7 China Hepatitis B and C Diagnostics Development Status and Outlook

      • 7.1 China Hepatitis B and C Diagnostics Market Size (2013-2018)
      • 7.2 China Hepatitis B and C Diagnostics Market Size and Market Share by Players (2013-2018)
      • 7.3 China Hepatitis B and C Diagnostics Market Size by Application (2013-2018)

      8 Japan Hepatitis B and C Diagnostics Development Status and Outlook

      • 8.1 Japan Hepatitis B and C Diagnostics Market Size (2013-2018)
      • 8.2 Japan Hepatitis B and C Diagnostics Market Size and Market Share by Players (2013-2018)
      • 8.3 Japan Hepatitis B and C Diagnostics Market Size by Application (2013-2018)

      9 Southeast Asia Hepatitis B and C Diagnostics Development Status and Outlook

      • 9.1 Southeast Asia Hepatitis B and C Diagnostics Market Size (2013-2018)
      • 9.2 Southeast Asia Hepatitis B and C Diagnostics Market Size and Market Share by Players (2013-2018)
      • 9.3 Southeast Asia Hepatitis B and C Diagnostics Market Size by Application (2013-2018)

      10 India Hepatitis B and C Diagnostics Development Status and Outlook

      • 10.1 India Hepatitis B and C Diagnostics Market Size (2013-2018)
      • 10.2 India Hepatitis B and C Diagnostics Market Size and Market Share by Players (2013-2018)
      • 10.3 India Hepatitis B and C Diagnostics Market Size by Application (2013-2018)

      11 Market Forecast by Regions, Type and Application (2018-2025)

      • 11.1 Global Hepatitis B and C Diagnostics Market Size (Value) by Regions (2018-2025)
        • 11.1.1 United States Hepatitis B and C Diagnostics Revenue and Growth Rate (2018-2025)
        • 11.1.2 Europe Hepatitis B and C Diagnostics Revenue and Growth Rate (2018-2025)
        • 11.1.3 China Hepatitis B and C Diagnostics Revenue and Growth Rate (2018-2025)
        • 11.1.4 Japan Hepatitis B and C Diagnostics Revenue and Growth Rate (2018-2025)
        • 11.1.5 Southeast Asia Hepatitis B and C Diagnostics Revenue and Growth Rate (2018-2025)
        • 11.1.6 India Hepatitis B and C Diagnostics Revenue and Growth Rate (2018-2025)
      • 11.2 Global Hepatitis B and C Diagnostics Market Size (Value) by Type (2018-2025)
      • 11.3 Global Hepatitis B and C Diagnostics Market Size by Application (2018-2025)

      12 Hepatitis B and C Diagnostics Market Dynamics

      • 12.1 Hepatitis B and C Diagnostics Market Opportunities
      • 12.2 Hepatitis B and C Diagnostics Challenge and Risk
        • 12.2.1 Competition from Opponents
        • 12.2.2 Downside Risks of Economy
      • 12.3 Hepatitis B and C Diagnostics Market Constraints and Threat
        • 12.3.1 Threat from Substitute
        • 12.3.2 Government Policy
        • 12.3.3 Technology Risks
      • 12.4 Hepatitis B and C Diagnostics Market Driving Force
        • 12.4.1 Growing Demand from Emerging Markets
        • 12.4.2 Potential Application

      13 Market Effect Factors Analysis

      • 13.1 Technology Progress/Risk
        • 13.1.1 Substitutes
        • 13.1.2 Technology Progress in Related Industry
      • 13.2 Consumer Needs Trend/Customer Preference
      • 13.3 External Environmental Change
        • 13.3.1 Economic Fluctuations
        • 13.3.2 Other Risk Factors

      14 Research Finding/Conclusion

        15 Appendix

          Methodology

            Analyst Introduction

              Data Source

              This report studies the global Hepatitis B and C Diagnostics market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Hepatitis B and C Diagnostics market by companies, region, type and end-use industry.

              Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.
              The increasing demand for molecular diagnostic of HBV (hepatitis B virus) and HCV (hepatitis C virus) infections is one of the primary drivers for the growth of this market. Molecular diagnosis simplifies sample preparation for high-volume testing and includes identification and profiling of causative agents of infection and the quantification of pathogens to monitor durability of therapy; thus, resulting in sales of around 60% of the overall molecular diagnosis market. Additionally, new companies are also focusing on the development of new products, which, in turn, is expected to change market dynamics for the diagnosis of HBV and HCV infections. For instance, Cepheid recently announced a quantitative test that offers on-demand molecular testing for confirmation of infection and monitoring of HCV and has obtained CE-IVD (in vitro diagnostics) status under the European Directive on in-vitro diagnostic medical devices, making it one of the leading platforms for molecular diagnosis.
              Increasing incidence of HBV and HCV infections in the Americas will contribute to the growth of the diagnostic market. The Americas will dominate the market, accounting for half of the total market share by 2023. The recent increase in blood transfusion will result in the adoption of third-generation hepatitis C diagnostic tests like HCV enzyme immunoassay that contribute to the growth of the market in this region. Also, the implementation of biomarker-based POC (point-of-care) tests initiated by the government and non-profit organizations, is also expected to drive the market growth as the products are highly accessible and easy to use.
              In 2017, the global Hepatitis B and C Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

              This report focuses on the global top players, covered
              Roche Diagnostics
              Abbott
              Siemens
              Qiagen
              Alere
              bioMérieux
              Cepheid
              Chembio Diagnostics
              DiaSorin
              Enzo Life Sciences
              Hologic
              MedMira
              OraSure Technologies
              Quest Diagnostics
              Quidel Corp
              Randox Laboratories

              Market segment by Regions/Countries, this report covers
              United States
              Europe
              China
              Japan
              Southeast Asia
              India

              Market segment by Type, the product can be split into
              Hepatitis B
              Hepatitis C

              Market segment by Application, split into
              Immunodiagnostics
              Nucleic Acid Test (NAT)

              The study objectives of this report are:
              To study and forecast the market size of Hepatitis B and C Diagnostics in global market.
              To analyze the global key players, SWOT analysis, value and global market share for top players.
              To define, describe and forecast the market by type, end use and region.
              To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
              To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
              To identify significant trends and factors driving or inhibiting the market growth.
              To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
              To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
              To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
              To strategically profile the key players and comprehensively analyze their growth strategies.

              In this study, the years considered to estimate the market size of Hepatitis B and C Diagnostics are as follows:
              History Year: 2013-2017
              Base Year: 2017
              Estimated Year: 2018
              Forecast Year 2018 to 2025
              For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

              Key Stakeholders
              Hepatitis B and C Diagnostics Manufacturers
              Hepatitis B and C Diagnostics Distributors/Traders/Wholesalers
              Hepatitis B and C Diagnostics Subcomponent Manufacturers
              Industry Association
              Downstream Vendors

              Available Customizations
              With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
              Regional and country-level analysis of the Hepatitis B and C Diagnostics market, by end-use.
              Detailed analysis and profiles of additional market players.




              Summary:
              Get latest Market Research Reports on Hepatitis B and C Diagnostics. Industry analysis & Market Report on Hepatitis B and C Diagnostics is a syndicated market report, published as Global Hepatitis B and C Diagnostics Market Size, Status and Forecast 2025. It is complete Research Study and Industry Analysis of Hepatitis B and C Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


              REPORT YOU MIGHT BE INTERESTED

              Purchase this Report

              $3,300.00
              $6,600.00
              2,215.95
              4,431.90
              3,036.66
              6,073.32
              399,762.00
              799,524.00
              218,834.22
              437,668.44
              Add To Cart Credit card Logo

              Related Reports


              Reason to Buy

              Request for Sample of this report